PL3750538T3 - Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę - Google Patents

Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Info

Publication number
PL3750538T3
PL3750538T3 PL20182691.4T PL20182691T PL3750538T3 PL 3750538 T3 PL3750538 T3 PL 3750538T3 PL 20182691 T PL20182691 T PL 20182691T PL 3750538 T3 PL3750538 T3 PL 3750538T3
Authority
PL
Poland
Prior art keywords
silodosin
male contraception
hormonal methods
hormonal
methods
Prior art date
Application number
PL20182691.4T
Other languages
English (en)
Inventor
Guillaume El Glaoui
Mehdi El Glaoui
Philippe Perrin
Stéphane DROUPY
Véronique AGATHON-MERIAU
Original Assignee
Pharmajor International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmajor International filed Critical Pharmajor International
Publication of PL3750538T3 publication Critical patent/PL3750538T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PL20182691.4T 2018-03-23 2019-03-22 Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę PL3750538T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328 2018-03-23

Publications (1)

Publication Number Publication Date
PL3750538T3 true PL3750538T3 (pl) 2024-11-25

Family

ID=65955198

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19714150T PL3562485T3 (pl) 2018-03-23 2019-03-22 Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny
PL20182691.4T PL3750538T3 (pl) 2018-03-23 2019-03-22 Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL19714150T PL3562485T3 (pl) 2018-03-23 2019-03-22 Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny

Country Status (19)

Country Link
US (3) US10912762B2 (pl)
EP (2) EP3750538B1 (pl)
JP (1) JP7270901B2 (pl)
KR (1) KR102496504B1 (pl)
CN (1) CN112074269A (pl)
AU (1) AU2019237228B2 (pl)
BR (1) BR112020018925A2 (pl)
CA (1) CA3094016C (pl)
DK (2) DK3562485T3 (pl)
ES (2) ES2989170T3 (pl)
FI (1) FI3750538T3 (pl)
IL (1) IL277372B2 (pl)
MA (1) MA53626B1 (pl)
MX (1) MX2020009937A (pl)
PL (2) PL3562485T3 (pl)
PT (1) PT3562485T (pl)
SG (1) SG11202008794TA (pl)
UA (1) UA128502C2 (pl)
WO (1) WO2019180217A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2989170T3 (es) * 2018-03-23 2024-11-25 Pharmajor Int Métodos no hormonales para la anticoncepción masculina que comprenden (R)-silodosina
JP2025539323A (ja) * 2022-11-23 2025-12-05 ファーマジョール インコーポレイテッド 放出調節シロドシン組成物および男性避妊のための方法におけるその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
KR20020086905A (ko) 2000-02-15 2002-11-20 쉐링 악티엔게젤샤프트 노르에티스테론을 포함하는 남성 피임약 제형
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
CL2007002851A1 (es) * 2006-10-05 2008-01-18 M S Panacea Biotec Ltd Composicion inyectable que comprende micro o nano -particulas biodegradables que incluyen un agente activo, un polimero biodegardable, un agente para intensificar la viscosidad y excipiente farmaceuticamente aceptables; y procedimientos de preparacion
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
WO2008106536A1 (en) 2007-02-28 2008-09-04 Kissei Pharmaceuticals Co., Ltd. Use of silodosin in a once daily administration for treating benign prostatic hyperplasia
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
JPWO2016051782A1 (ja) 2014-09-30 2017-07-13 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
ES2989170T3 (es) * 2018-03-23 2024-11-25 Pharmajor Int Métodos no hormonales para la anticoncepción masculina que comprenden (R)-silodosina

Also Published As

Publication number Publication date
RU2020134408A (ru) 2022-04-29
AU2019237228B2 (en) 2023-06-08
MA53626A (fr) 2022-03-09
IL277372B2 (en) 2023-09-01
US20190290615A1 (en) 2019-09-26
US11951095B2 (en) 2024-04-09
MA53626B1 (fr) 2024-09-30
CA3094016A1 (en) 2019-09-26
FI3750538T3 (fi) 2024-09-24
DK3750538T3 (da) 2024-09-23
EP3562485B1 (en) 2020-07-01
DK3562485T3 (da) 2020-08-24
US20210113526A1 (en) 2021-04-22
PT3562485T (pt) 2020-08-27
CA3094016C (en) 2023-10-10
EP3562485A1 (en) 2019-11-06
ES2989170T3 (es) 2024-11-25
US10912762B2 (en) 2021-02-09
RU2020134408A3 (pl) 2022-04-29
JP7270901B2 (ja) 2023-05-11
WO2019180217A1 (en) 2019-09-26
SG11202008794TA (en) 2020-10-29
BR112020018925A2 (pt) 2020-12-29
US20230145374A1 (en) 2023-05-11
CN112074269A (zh) 2020-12-11
IL277372A (en) 2020-11-30
UA128502C2 (uk) 2024-07-31
JP2021518438A (ja) 2021-08-02
IL277372B1 (en) 2023-05-01
PL3562485T3 (pl) 2020-11-16
AU2019237228A1 (en) 2020-10-01
EP3750538B1 (en) 2024-08-14
ES2813084T3 (es) 2021-03-22
EP3750538A1 (en) 2020-12-16
NZ767741A (en) 2024-11-29
KR20200135978A (ko) 2020-12-04
MX2020009937A (es) 2022-09-30
EP3562485B8 (en) 2020-08-19
KR102496504B1 (ko) 2023-02-06
US11583518B2 (en) 2023-02-21

Similar Documents

Publication Publication Date Title
GB201910775D0 (en) No Details
EP3242631A4 (en) Prosthesis for improved penis function
SI3525733T1 (sl) Priprava za vstavljanje za intrauterini sistem
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
GB201908106D0 (en) No details
SG11201906685UA (en) METHOD FOR FORMING Si-CONTAINING FILM
PL3750538T3 (pl) Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
CA194457S (en) Pouch
GB2588316B (en) Earplugs
GB201905867D0 (en) No details
PT3750538T (pt) Métodos não-hormonais para a contracepção masculina compreendendo (r)-silodosina
GB2611270B (en) Kimono
SMT202400035T1 (it) Formulazione intravaginale
HK40012009B (en) Non-hormonal compositions and methods for male contraception comprising (r)-silodosin
HK40012009A (en) Non-hormonal compositions and methods for male contraception comprising (r)-silodosin
HK40118185A (zh) 用於子宫内系统的插入器
GB2577060B (en) Adaptor
GB201912486D0 (en) No details
GB201904663D0 (en) No details
GB201814535D0 (en) Intraocular devices
GB201913500D0 (en) No details
GB201908250D0 (en) No details
GB201809800D0 (en) No details
GB201809802D0 (en) No details
GB201809801D0 (en) No details